Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statistical shortcomings in licensing applications

J A Lewis1, K M Facey

  • 1Medicines Control Agency, Market Towers, London, U.K. jal@lewisja.demon.co.uk

Statistics in Medicine
|September 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seed Treatment with a Fungal or a Bacterial Antagonist for Reducing Corn Damping-off Caused by Species of Pythium and Fusarium.

Plant disease·2019
Same author

Seed Treatment Using Pre-infiltration and Biocontrol Agents to Reduce Damping-off of Corn Caused by Species of Pythium and Fusarium.

Plant disease·2019
Same author

A Formulation of Trichoderma and Gliocladium to Reduce Damping-off Caused by Rhizoctonia solani and Saprophytic Growth of the Pathogen in Soilless Mix.

Plant disease·2019
Same author

3D printed structures for modeling the Young's modulus of bamboo parenchyma.

Acta biomaterialia·2018
Same author

Tactic-specific benefits of polyandry in Chinook salmon Oncorhynchus tshawytscha.

Journal of fish biology·2016
Same author

Evaluation of the Pulmonary Toxicity of Ambient Particulate Matter From Camp Victory, Iraq.

Journal of toxicology and environmental health. Part A·2015

Statistical work in clinical trials for regulatory purposes shows improvement but still has shortcomings. Issues include non-adherence to standard practices, misunderstanding statistical disagreements, and improper use of advanced methods, alongside reporting inadequacies.

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Regulatory Science

Background:

  • Statistical methodologies in clinical trials have advanced significantly.
  • While overall quality is high, specific areas of statistical practice require attention.
  • Regulatory requirements necessitate rigorous statistical analysis and reporting.

Purpose of the Study:

  • To evaluate the current state of statistical work in regulatory clinical trials.
  • To identify and exemplify common shortcomings in statistical practice and reporting.
  • To highlight the importance of statistical contributions in regulatory submissions.

Main Methods:

  • Review of statistical practices in regulatory clinical trials.
  • Analysis of common errors and deficiencies.

Related Experiment Videos

  • Case examples illustrating statistical issues.

    • Main Results:

    • General improvement in statistical work quality over recent years.
    • Persistent shortcomings include deviation from established statistical practices.
    • Challenges identified in understanding statistical disagreements and applying advanced techniques.
    • Inadequate reporting of statistical methods and results is prevalent.

    Conclusions:

    • Despite improvements, statistical work in regulatory trials faces challenges.
    • Adherence to best practices and clear reporting are crucial for trial integrity.
    • Enhanced statistical expertise and oversight are needed for robust regulatory submissions.